AZITHROMYCIN AND CO-AMOXICLAV AT DIFFERENT DOSAGES HAVE BEEN PROMOTED FOR TREATING CHILDREN WITH LOWER RESPIRATORY TRACT INFECTIONS. Cuestiones de Fisioterapia, [S. l.], v. 53, n. 02, p. 5041–5046, 2026. DOI: 10.48047/dhpsth87. Disponível em: https://cuestionesdefisioterapia.com/index.php/es/article/view/3961.. Acesso em: 25 feb. 2026.